30 Oct 2019 Unique Alzheimer's Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies
29 Oct 2019 Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
29 Oct 2019 GSK candidate vaccine demonstrates sustained level of protection against active pulmonary tuberculosis
29 Oct 2019 RhoVac Receives Approval in Finland to Start Clinical Phase IIb Study in Prostate Cancer
23 Oct 2019 BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
18 Oct 2019 Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
18 Oct 2019 Merck Receives EU CHMP Positive Opinion for Investigational V920 Ebola Zaire Vaccine for Protection Against Ebola Virus Disease
17 Oct 2019 Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy
15 Oct 2019 Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
08 Oct 2019 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
08 Oct 2019 Prokarium Secures £4.6M from Wellcome to Fund the Clinical Development of its Lead Vaccine Programme
08 Oct 2019 Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
04 Oct 2019 Caliviri Demonstrates That RNA Processing Errors Are a Rich Source of Tumor Neoantigens for Cancer Vaccines
02 Oct 2019 Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines
01 Oct 2019 Themis Bioscience and ZIKAVAX Consortium Announce Initiation of Phase 1 Zika Vaccine Trial
30 Sep 2019 Preliminary Results From IMV’s Phase 2 Basket Trial Evaluating DPX-Survivac as a Combination Therapy in Patients With Advanced and Metastatic Solid Tumors to Be Presented at ESMO Congress 2019
27 Sep 2019 Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study
27 Sep 2019 Treos Bio Reports Updated Positive Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
27 Sep 2019 AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes
27 Sep 2019 Meissa Vaccines Closes $30 Million Financing to Advance RSV Vaccine into Clinical Trials
27 Sep 2019 Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101
25 Sep 2019 Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial
25 Sep 2019 Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
22 Sep 2019 LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
19 Sep 2019 PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up